RecallRadar

FDA Device recall Z-3179-2018

VITEK(R) 2 AST-P640, For susceptibility testing of Staphylococcus spp

On 2018-09-26 the FDA classified a Class II recall of VITEK(R) 2 AST-P640, For susceptibility testing of Staphylococcus spp by Biomerieux, citing routine internal review of Device History Records identified six VITEK(R) 2 AST card lots were manufactured with less drug (gentamicin) than required for the Gentamicin High-Level….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-3179-2018
ClassificationClass II
Statusterminated
Initiated2018-08-13
Published2018-09-26
Last updated2026-09-13 11:54 UTC
CompanyBiomerieux
DistributionUS

Product

VITEK(R) 2 AST-P640, For susceptibility testing of Staphylococcus spp. Enterococcus spp., ad S agalactiae against specified antimicrobials, REF 418579 Product Usage: VITEK¿ 2 is an automated system consisting of instruments, software and reagent cards designed for the identification and antimicrobial susceptibility testing of bacteria and yeast. The VITEK¿ 2 utilizes growth-based biochemical patterns to determine identification. The VITEK¿ 2 provides minimal inhibitory concentration (MIC) results for most organism/drug combinations as well as a category interpretation (S, I, or R) consistent with accepted criteria.

Reason

Routine internal review of Device History Records identified six VITEK(R) 2 AST card lots were manufactured with less drug (gentamicin) than required for the Gentamicin High-Level Resistance (ghlr01n) screen test due to an error when making 1500mL and 2000mL media well preparations (solutions).

Identifiers

code_infoLot Numbers: 7400410103, 7400697403

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-3179-2018%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.